Fluid Correction Optimizes Interpretation of Serum Creatinine for Acute Kidney Injury Identification in Premature Neonates: Secondary Analysis of the PENUT Trial

Saturday, April 29, 2023

4:00 PM – 4:15 PM ET

Location: Convention Center: 150 A

Publication Number: 1570.3

Michelle C. Starr, Indiana University School of Medicine, Indinapolis, IN, United States; Russell Griffin, University of Alabama at Birmingham, Birmingham, AL, United States; Matthew Harer, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States; Danielle Soranno, Indiana University, Indianapolis, IN, United States; Katja M. Gist, Children's Hospital Medical Center (Cincinnati), Cincinnati, OH, United States; Jeffrey Segar, Medical College of Wisconsin, Milwaukee, WI, United States; Shina Menon, University of Washington School of Medicine, Seattle, WA, United States; Lindsey Gordon, Children's of Alabama, Birmingham, AL, United States; David Askenazi, University of Alabama at Birmingham, BIRMINGHAM, AL, United States; David Selewski, Medical University of South Carolina, Mount Pleasant, SC, United States

Presenting Author(s)

Michelle C. Starr, MD MPH (she/her/hers)
Assistant Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Nephrology
Indiana University School of Medicine
Indinapolis, Indiana, United States

Disclosure(s):

Michelle C. Starr, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Russell Griffin, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Matthew Harer, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Danielle Soranno, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Katja M. Gist, DO, MSc: BioPorto Diagnostics (Ongoing) (Products/Services: Consultant); Potrero Medical (Ongoing) (Products/Services: Consultant)

Jeffrey Segar, MD: Pfizer (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)

Shina Menon, MD: Gerber Foundation (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Medtronic (Ongoing) (Products/Services: Consultant); Nuwellis (Ongoing) (Products/Services: Consultant)

Lindsey Gordon, DO: I do not have any relevant financial / non-financial relationships with any proprietary interests.

David Askenazi, MD, MSPH: Baxter (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Bioporto (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Medtronic (Ongoing) (Products/Services: Consultant); Nuwellis (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Seastar (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Zorro-Flow Inc. (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)

David Selewski, MD, MSCR: Travere (Terminated, July 5, 2021) (Products/Services: Consultant)